ArticleCancer reports (Hoboken, N.J.)2024

Individualized targeted treatment in a case of a rare TFG::ROS1 fusion positive inflammatory myofibroblastic tumor (IMT).

Sebastian Sommer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.